# BioReason-Pro RL Review: KEAP1 (human)

Source: KEAP1-deep-research-bioreason-rl.md

- **Correctness**: 3/5
- **Completeness**: 2/5

The BioReason-Pro RL analysis correctly identifies the BTB-BACK-Kelch domain architecture of KEAP1 and recognizes it as a substrate adaptor for a cullin-based E3 ubiquitin ligase complex. The structural reasoning from domains is largely accurate. However, the analysis fails to identify KEAP1's actual biological role and instead defaults to generic predictions.

**What it got right:**
- BTB-BACK-Kelch domain architecture correctly identified and ordered
- BTB domain mediates dimerization and cullin adaptor docking
- Kelch beta-propeller recognized as a substrate-binding platform
- Cytoplasmic localization
- Recognition that the protein participates in ubiquitin ligase complex assembly

**What it got wrong or missed:**
- The primary molecular function is described as "protein binding" (GO:0005515) rather than the far more specific and accurate "ubiquitin-like ligase-substrate adaptor activity" (GO:1990756), which is accepted in the curated review
- The biological process is assigned as "actin cytoskeleton organization" (GO:0030036), which is incorrect. While Kelch domains can bind actin in some family members, KEAP1's Kelch domain binds the Neh2 domain of NRF2, not actin. This is a clear case of fold-bias: the system assumed Kelch = actin binding because some Kelch proteins bind actin.
- The central function of KEAP1 -- redox sensing via reactive cysteine residues (Cys151, Cys273, Cys288) and regulation of NRF2-mediated antioxidant transcription -- is completely absent
- No mention of NRF2 (NFE2L2) as the primary substrate, which is THE defining biological relationship of KEAP1
- No mention of the CUL3-RBX1 complex or the BCR(KEAP1) E3 ligase
- No mention of oxidative/electrophilic stress sensing
- No mention of SQSTM1/p62-mediated autophagy regulation of KEAP1
- No mention of the cancer relevance (KEAP1 loss-of-function mutations in lung cancer)
- The "Functional Summary" describes KEAP1 as coordinating "cytoskeletal remodeling with selective substrate recruitment" which is fundamentally wrong

**Failure modes observed:**
- Fold-bias: Kelch beta-propeller predicted to bind actin-associated factors based on the general properties of Kelch domains, ignoring that KEAP1's Kelch domain is specific for NRF2 Neh2 degron motifs
- Architecture-only reasoning: The system correctly identifies the E3 ligase adaptor architecture but fails to identify the specific substrate or pathway, defaulting to generic cytoskeletal functions
- Missing the entire oxidative stress / transcriptional regulation axis that is the raison d'etre of KEAP1

The curated review, by contrast, provides a thorough and accurate description of KEAP1 as the substrate adaptor of the BCR(KEAP1) E3 ubiquitin ligase targeting NRF2 for degradation, with detailed coverage of the cysteine-based redox sensing mechanism, SQSTM1/p62 regulation, and cancer relevance.
